Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2026-08 · 45 (4) · 69-75
DOI: 10.1177/21679436261461702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, online erschienen am 16.06.2026. Verfasst von Miu Hirose und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Epitope Mapping, Antibodies, Monoclonal, Epitopes, Peptides. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Leukocyte migration is a fundamental process in both innate and adaptive immune responses. This process is tightly regulated by chemokines and their cognate receptors. The bioavailability of chemokines is further modulated by atypical chemokine receptors (ACKRs), a subset of chemokine receptor–like molecules that lack coupling to canonical G protein–mediated signaling pathways. Among these, ACKR4 regulates dendritic cell migration through ligand scavenging and has been implicated in tumor progression in murine models. We previously established anti-mouse ACKR4 (mACKR4) mAbs, A 4 Mab-1, A 4 Mab-2, and A 4 Mab-3, by N-terminal peptide immunization. This study examined the binding epitopes of A 4 Mabs. Alanine (or glycine) scanning within the N-terminal region (amino acids 2–19) was performed using flow cytometry and Western blotting. Results showed that Tyr12 is required for recognition by A 4 Mab-1 in flow cytometry, whereas Tyr11, Tyr12, Glu14, Glu15, and Glu17 are required in Western blotting. For A 4 Mab-2, Tyr12, Glu15, and Asn16 are required in flow cytometry, whereas Tyr11, Tyr12, Tyr13, Glu15, and Asn16 are required in Western blotting. Additionally, Glu14, Asn16, and Glu17 are required for recognition by A 4 Mab-3 in flow cytometry. These findings contribute to the understanding of mACKR4 recognition by A 4 Mabs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Yukinari Kato
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Hirose, M., Tanaka, T., Yanaka, M., Nakamura, T., Kaneko, M. K., Suzuki, H., & Kato, Y. (2026). Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 45(4), 69-75. https://doi.org/10.1177/21679436261461702
Vancouver
Hirose M, Tanaka T, Yanaka M, Nakamura T, Kaneko MK, Suzuki H, et al. Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2026;45(4):69-75. doi:10.1177/21679436261461702
BibTeX
@article{Hirose2026,
author = {Hirose, Miu and Tanaka, Tomohiro and Yanaka, Miyuki and Nakamura, Takuro and Kaneko, Mika K and Suzuki, Hiroyuki and Kato, Yukinari},
title = {Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization},
journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
year = {2026},
volume = {45},
number = {4},
pages = {69--75},
doi = {10.1177/21679436261461702}
}
EUVIMED